FDA staff backs Kythera's injection to reduce double chin

(Reuters) - Kythera Biopharmaceuticals Inc's injection for "double chin" reduction was backed by U.S. Food and Drug Administration staff, who concluded the drug's benefits outweighed its risks.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1zPy93U